title: Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
abstract: The aim of this study is to determine the efficacy of exoantigens derived from Babesia gibsoni cultures to induce protective immunity against challenge exposure of virulent organisms. An attenuated B. gibsoni Oita strain was maintained in vitro by the microaerophilus stationary phase (MASP) method, and exoantigens-containing supernatant fluids were collected for preparation of the immunization. Two dogs received three subcutaneous immunizations with a 20-day interval of B. gibsoni exoantigens plus 0.5 mg saponin (Quil A). On day 68 after the prime immunization, the immunized dogs and control dogs were challenged intravenously with 2 × 10(8) virulent parasites of a homologous B. gibsoni strain. The results showed that exoantigens could induce a high degree of protection against virulent homologous challenge exposure. Two dogs immunized with exoantigens showed a lower parasitemia, accompanied by a slight decrease in the PCV that returned to normal values. Control dogs developed typical acute clinical signs, including severe anemia and hyperthermia. The immunization elicited humoral immune responses. In dogs immunized with exoantigens, the maximum antibody titer was 2,560 and 5,120 by indirect fluorescent antibody test (IFAT), respectively. Preliminary Western blot analysis of the immunogen revealed five dominant proteins of molecular weights of 18, 37, 43, 50, and 57 kDa. These results suggested that the culture-derived exoantigens were candidates for non-viable vaccine.
authors.affiliation: Laboratory of Infectious Disease, School of Veterinary Medicine, Azabu University, Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa, 252-5201, Japan, sunaga@azabu-u.ac.jp.
authors.forename: Fujiko
authors.initials: F
authors.lastname: Sunaga
authors.forename: Sachiko
authors.initials: S
authors.lastname: Arai
authors.forename: Seigo
authors.initials: S
authors.lastname: Itoh
authors.forename: Satoshi
authors.initials: S
authors.lastname: Taharaguchi
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000276:immunology*; D001403:Babesia / Q000276:immunology / Q000472:pathogenicity*; D001404:Babesiosis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D004283:Dog Diseases / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D056724:Immunity, Humoral; D018512:Parasitemia / Q000517:prevention & control; D016052:Protozoan Vaccines / Q000276:immunology*
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016052:Protozoan Vaccines